Donna M. Edwards

531 total citations
40 papers, 278 citations indexed

About

Donna M. Edwards is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Donna M. Edwards has authored 40 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Donna M. Edwards's work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Donna M. Edwards is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Donna M. Edwards collaborates with scholars based in United States, Argentina and United Kingdom. Donna M. Edwards's co-authors include Douglas K Owens, Ross D. Shachter, Pierrick G.J. Fournier, Todd H. West, David. Reichmuth, Shoji Ichikawa, Erik A. Imel, Attaya Suvannasankha, George E. Sandusky and Garrett Barter and has published in prestigious journals such as Cancer Research, The Lancet Oncology and Journal of Cell Science.

In The Last Decade

Donna M. Edwards

33 papers receiving 263 citations

Peers

Countries citing papers authored by Donna M. Edwards

Since Specialization

Citations

This map shows the geographic impact of Donna M. Edwards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna M. Edwards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna M. Edwards more than expected).

Fields of papers citing papers by Donna M. Edwards

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna M. Edwards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna M. Edwards. The network helps show where Donna M. Edwards may publish in the future.

Co-authorship network of co-authors of Donna M. Edwards

This figure shows the co-authorship network connecting the top 25 collaborators of Donna M. Edwards. A scholar is included among the top collaborators of Donna M. Edwards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna M. Edwards. Donna M. Edwards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker 2025 ·European Journal of Clinical Pharmacology ·David E. Coutant, Jessica Rehmel, Donna M. Edwards, Stephen D. Hall	0
2	Effect of Prepectoral Versus Subpectoral Implant-Based Reconstruction on Post-Mastectomy Radiation Dosimetry 2025 ·Annals of Surgical Oncology ·(unknown), (unknown), Donna M. Edwards, Robin B. Marsh, Jennifer Shah, Lori J. Pierce, Corey Speers, Adeyiza O. Momoh	1
3	Granulopoietic Dysregulation in a Patient-Tailored Mouse Model of Barth Syndrome 2025 ·PubMed ·(unknown), Maegan L. Capitano, Donna M. Edwards, Baskar Ramdas, Scott Cooper, James Ropa, (unknown), (unknown), Paige Snider, Hilary J. Vernon, Ngoc Tung Tran, Reuben Kapur, Simon J. Conway	0
4	The Loss of Tafazzin Transacetylase Activity Is Sufficient to Drive Testicular Infertility 2024 ·Journal of Developmental Biology ·Paige Snider, (unknown), (unknown), Donna M. Edwards, Jeffrey J. Brault, Simon J. Conway	2
5	Pan‐Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System 2024 ·Cancer Medicine ·(unknown), Matthew J. Schipper, Lars G. Fritsche, (unknown), Garth W. Strohbehn, Erkin Ötleş, Benjamin H. McMahon, Silvia Crivelli, (unknown), Nithya Ramnath, Shinjae Yoo, (unknown), K. Nathan Sankar, Donna M. Edwards, Steven G. Allen, Michael D. Green, Alex K. Bryant	4
6	Phase 2 Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients With Locally Advanced Non-Small Cell Lung Cancer 2024 ·International Journal of Radiation OncologyBiologyPhysics ·Donna M. Edwards, Caitlin A. Schonewolf, John D. Rice, Matthew J. Schipper, Randall K. Ten Haken, M.M. Matuszak, James M. Balter, (unknown), Douglas A. Arenberg, Morand Piert, Angel Qin, Gregory P. Kalemkerian, Bryan J. Schneider, Nithya Ramnath, Christina Chapman, David A. Elliott, Theodore S. Lawrence, Jason W.D. Hearn, James A. Hayman, Shruti Jolly	0
7	Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study 2024 ·The Lancet Oncology ·(unknown), (unknown), Matthew J. Schipper, (unknown), Garth W. Strohbehn, Beth Wallace, (unknown), (unknown), Benjamin H. McMahon, (unknown), Nithya Ramnath, (unknown), K. Nathan Sankar, Donna M. Edwards, Steven G. Allen, Shinjae Yoo, Silvia Crivelli, Michael D. Green, Alex K. Bryant	3
8	Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era 2024 ·The Cancer Journal ·Donna M. Edwards, Michelle M. Kim	1
9	Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Donna M. Edwards, K. Nathan Sankar, (unknown), (unknown), Matthew J. Schipper, (unknown), (unknown), Garth W. Strohbehn, David A. Elliott, Drew Moghanaki, Nithya Ramnath, Michael D. Green, Alex K. Bryant	8
10	Association of Proton Pump Inhibitor Use and Severe Pneumonitis in Stage III Non-Small-Cell Lung Cancer Treated with Primary Chemoradiation and Adjuvant Durvalumab 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Grace Sun, Donna M. Edwards, (unknown), David A. Elliott, Daniel A. Hamstra, (unknown), Michael D. Green, Alex K. Bryant	1
11	External beam management of stage I and II uterine cancer 2022 ·International Journal of Gynecological Cancer ·Donna M. Edwards, Shruti Jolly	1
12	Differential Iron Requirements for Osteoblast and Adipocyte Differentiation 2021 ·JBMR Plus ·Donna M. Edwards, Christopher J. Miller, (unknown), Christian S. Wright, Matthew Prideaux, Gerald J. Atkins, William R. Thompson, Erica L. Clinkenbeard	12
13	SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA ‐deficient cells 2021 ·Molecular Oncology ·(unknown), Zahi Abdul Sater, (unknown), (unknown), Richa Sharma, Donna M. Edwards, Ying He, Grzegorz Nalepa, Steven D. Rhodes, D. Wade Clapp, (unknown)	3
14	Suppression of Sost/Sclerostin and Dickkopf-1 Augment Intervertebral Disc Structure in Mice 2020 ·Journal of Bone and Mineral Research ·(unknown), (unknown), Paul Niziolek, Donna M. Edwards, (unknown), Erica L. Clinkenbeard, Alexander G. Robling, Nilsson Holguin	12
15	Impact of Lung Parenchymal-Only Failure on Overall Survival in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiotherapy 2020 ·Clinical Lung Cancer ·May Elbanna, Kevin Shiue, Donna M. Edwards, (unknown), Namita Agrawal, (unknown), (unknown), (unknown), (unknown), Jessica L. Smith, (unknown), Heather Burney, Yong Zang, Jordan A. Holmes, Márk Langer, Richard C. Zellars, Tim Lautenschlaeger	2
16	Whole-exome sequencing enables correct diagnosis and surgical management of rare inherited childhood anemia 2018 ·PMC ·(unknown), Donna M. Edwards, (unknown), Caroline Miller, (unknown), (unknown), Grzegorz Nalepa	0
17	Predictors of Nodal and Metastatic Failure in Early Stage Non–small-cell Lung Cancer After Stereotactic Body Radiation Therapy 2018 ·Clinical Lung Cancer ·(unknown), (unknown), (unknown), Kevin Shiue, (unknown), (unknown), Christopher R. Deig, Donna M. Edwards, (unknown), Susannah G. Ellsworth, Ke Huang, Khalil Diab, Márk Langer, Richard C. Zellars, Feng‐Ming Kong, Jun Wan, Tim Lautenschlaeger	4
18	Whole-exome sequencing enables correct diagnosis and surgical management of rare inherited childhood anemia 2018 ·Molecular Case Studies ·(unknown), Donna M. Edwards, (unknown), Caroline Miller, (unknown), (unknown), Grzegorz Nalepa	4
19	A Systematic Methodology for Selecting Decontamination Strategies Following a Biocontamination Event 2011 ·Biosecurity and Bioterrorism Biodefense Strategy Practice and Science ·(unknown), Donna M. Edwards, (unknown), Mark Tucker	11
20	The yeast endocytic protein Epsin 2 functions in a cell-division signaling pathway 2009 ·Journal of Cell Science ·Debarati Mukherjee, Brian G. Coon, Donna M. Edwards, (unknown), Silvia A. Longhi, J. Michael McCaffery, Beverly Wendland, (unknown), Erfei Bi, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact